Jing Jing Li

Jing Jing Li is a Senior Research Fellow at the Centre for Health Economics, Monash University Business School. She leads the Monash University Health Technology Assessment team, conducting high-impact evaluations that inform global health funding decisions for bodies such as the Pharmaceutical Benefits Advisory Committee (PBAC), Medical Services Advisory Committee (MSAC), Australian Technical Advisory Group on Immunisation (ATAGI), and the Agency for Care Effectiveness in Singapore.

Research Interests: Her work spans health economics, healthcare decision-making, cancer care, cost-effectiveness analysis alongside clinical trials, and advanced decision analytic modelling. She focuses on translating complex health data into actionable policy insights, particularly in the areas of cancer treatment, paediatric health outcomes, and evaluation of new health technologies.

The recent publications reflect a strong trend in health technology assessment, policy-relevant economic evaluations, and contributions to global oncology guidelines. Her research increasingly integrates real-world evidence, surrogate endpoints in cancer trials, and value-based funding models, with a focus on improving health system efficiency and patient outcomes.

Scientific Awards:

• Business School Commendation for Research Impact 2020 – Recognized for policy and clinical guideline impact, with references in 1 policy source and 2 clinical guideline sources, and widespread dissemination across news outlets and social media.

Advising and Grants: Dr. Li has been the Primary Chief Investigator on multiple competitive research projects, including evaluations of cancer therapies, tools for valuing health change in children, and monitoring systems for cancer trial outcomes. She collaborates extensively with national and international health agencies, demonstrating strong grant leadership and advisory influence in health policy.

Labs and Teams: She leads the Monash University Health Technology Assessment team, a multidisciplinary group focused on generating evidence for health funding decisions. The team works closely with government and advisory bodies to ensure research directly informs public health policy and clinical practice.